Inozyme Pharma, Inc.

NASDAQ:INZY

1.38 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -24.57-27.033-23.347-21.544-16.638-15.583-17.404-18.544-16.372-15.261-16.884-18.754-14.28-12.54-11.05-11.118-28.095-9.473-7.738-6.544-4.036-4.173-4.971
Depreciation & Amortization 0.1950.1880.1820.3060.2080.2090.2070.1980.1890.1790.1780.1820.1670.1670.1580.1230.0430.0260.0250.0250.020.0190.019
Deferred Income Tax 000-3.128-1.484-1.104000000.0240.030.0580.058000000.00100
Stock Based Compensation 2.1262.1571.6911.6731.6721.62.0921.8861.8492.1851.7522.0221.7521.8131.5771.2730.7860.120.1290.1130.1070.040.041
Change In Working Capital -1.922.159-1.342.925-2.939-0.95-2.1182.4560.178-1.3890.7672.983-0.0650.376-3.209-1.29-0.9150.7291.3651.1160.611-0.771-0.355
Accounts Receivables 00000000000000000000000
Change In Inventory 00000000000000000000000
Change In Accounts Payables -1.3171.3611-0.843-0.0050.199-0.7291.1530.087-0.896-0.1941.807-0.201-0.908-1.3730.3541.29-0.2140.6680.358-0.048-0.339-0.054
Other Working Capital -0.6030.798-2.343.768-2.934-1.149-1.3891.3030.091-0.4930.9611.1760.1361.284-1.836-1.644-2.2050.9430.6970.7580.659-0.432-0.301
Other Non Cash Items -0.3590.043-0.6641.2810.3130.28-0.549-0.396-0.358-0.4010.0270.0990.0960.0930.090.13717.98-0.035-0.046-0.03-0.02-0.339-0.022
Operating Cash Flow -24.528-23.658-24.533-18.487-18.868-15.548-17.772-14.4-14.514-14.687-14.16-13.444-12.3-10.033-12.376-10.875-10.201-8.633-6.265-5.32-3.317-4.885-5.288
Investing Activities:
Investments In Property Plant And Equipment -0.0130-0.032-0.105-0.007-0.011-0.175-0.046-0.147-0.2-0.017-0.04-0.079-0.19-0.0880.185-0.585-0.067-0.101-0.017-0.0790-0.043
Acquisitions Net 0000.0060.0450.016-0.01400.0080.0230000000000000
Purchases Of Investments -27.714-49.46-49.324-57.865-104.59-60.816-46.059-25.986-44.36-51.226-30.421-16.973-42.959-23.486-38.549-52.432-106.582-5.5-13.408-8.653-3.238-9.097-3.674
Sales Maturities Of Investments 51.07567.27659.7551.559.98244.56029.2536.2528.55326.556.143.3539.2132.297.50111.41910.10134.1853.755.475
Other Investing Activites 017.81610.426-0.006-0.045-0.0160.0140-0.008-0.02322.5799.52713.14119.8640.661-20.142-99.0815.919-3.307-5.6530.947-5.3471.801
Investing Cash Flow 23.34817.81610.394-6.47-44.615-16.32713.7663.218-8.257-22.92622.5629.48713.06219.6740.573-19.957-99.6665.852-3.408-5.670.868-5.3471.758
Financing Activities:
Debt Repayment 00012.507.52004.0500000000000000
Common Stock Issued 10.440.4580.159-0.00269.56216.1420.0960-0.04268.3330.240.6090.2370.1120.249-0.9860000000
Common Stock Repurchased 000.1480000.09600000000-0.9860000000
Dividends Paid 00000000000000000000000
Other Financing Activities 00.4580.1590.0160.15316.1420.09600.16568.3330.240.0110.2370.1120.2490.03118.86131.9320.0050.0090.029022.932
Financing Cash Flow 10.5230.4580.15912.51669.71523.64220.09604.21568.3330.240.0110.2370.1120.249-0.986118.86131.9320.0050.0090.029022.932
Other Information:
Effect Of Forex Changes On Cash -0.001-0.0010.010.134-0.1820.0110.0190.053-0.02-0.043-0.0150.033-0.0090000000000
Net Change In Cash 9.653-5.385-13.97-12.3076.05-8.22216.109-11.129-18.57630.6778.627-3.9130.999.753-11.554-31.8188.99429.151-9.668-10.981-2.42-10.23219.402
Cash At End Of Period 24.88615.23320.61834.58847.20641.15649.37833.26944.39862.97432.29723.6727.58326.59316.8428.39460.21251.21822.06731.73542.71645.13655.368